Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19.
Front Med (Lausanne)
; 8: 743325, 2021.
Article
in English
| MEDLINE | ID: covidwho-1436007
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
Front Med (Lausanne)
Year:
2021
Document Type:
Article
Affiliation country:
Fmed.2021.743325
Similar
MEDLINE
...
LILACS
LIS